Amia Capital’s Gilead Sciences GILD Stock Holding History

Amia Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,746	Closed	-$308K	–	44
2019 Q4	$308K	Buy	+4,746	New	+$309K	0.09%	38

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Amia Capital's GILD Position: Q1 2020 in Review

Amia Capital sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 4,746 shares — an estimated $308K sold.

Amia Capital first reported a position in GILD in Q4 2019 and held it in 1 quarter. The position peaked at $308K in Q4 2019. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

Amia Capital reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
Amia Capital sold 4,746 Gilead Sciences shares in Q1 2020, an estimated $308K.
Amia Capital first reported a position in Gilead Sciences in Q4 2019 and held it in 1 quarter.
Amia Capital's Gilead Sciences position peaked at $308K in Q4 2019.
1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Amia Capital's 13F filing for Q1 2020, filed 15 May 2020.